MFS Research International R6
MRSKX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- Boston, MA 2199 Boston MA United States of America 2199
- IPO Date
- Apr 28, 2006
- CIK
- 0000798244
- Website
- mfs.com
- Similar Companies
- Business
- MFS Research International Fund (Class R6) (MRSKX) is an open-end mutual fund managed by MFS Investment Management that seeks capital appreciation by investing primarily in foreign equity securities, including those from emerging markets; the fund maintains a broadly diversified portfolio across sectors, regions, industries, styles, and market capitalizations with a focus on company-specific stock selection rather than country allocation. Core offerings include common stocks, depositary receipts, and other equity securities of non-U.S. companies, with at least 65% of assets typically allocated to such foreign equities; top holdings as of November 30, 2025, feature Roche Holding AG, Mizuho Financial Group Inc., Schneider Electric SE, Hitachi Ltd., and NatWest Group PLC, spanning financial services (26.75%), capital goods (23.98%), technology (11.54%), and health care (10.10%). The fund benchmarks against the MSCI EAFE Index and targets institutional and eligible retail investors seeking international large-blend exposure, with geographic operations emphasizing Europe ex-U.K. (41.40%), Japan (21.08%), the United Kingdom (16.42%), and North America (8.55%), including emerging markets exposure in Taiwan, India, and Brazil. Launched on January 2, 1997, with Class R6 shares commencing May 1, 2006, the fund is domiciled in the United States and headquartered at MFS Investment Management's offices in Boston, Massachusetts. Recent developments include a December 2025 distribution of short-term capital gains ($0.05108 per share), dividends ($0.55360 per share), and long-term capital gains ($0.84637 per share) paid on December 10; net assets stood at $17.66 billion as of November 30, 2025, reflecting ongoing portfolio management by a team including Nicholas Paul (since December 31, 2022) and John Mahoney (since January 1, 2024), amid MFS's late 2024 launch of five active ETFs as part of broader strategic expansion in investment vehicles. The fund features a net expense ratio of 0.63% (with waivers through at least December 31, 2025) and no sales charge for eligible R6 investors.